Variant report
Variant | nsv1030715 |
---|---|
Chromosome Location | chr7:11926347-11938607 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9655091 | chr7:11926347-11926348 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs184087380 | chr7:11926356-11926357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs142540831 | chr7:11926357-11926358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10242909 | chr7:11926366-11926367 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs368459253 | chr7:11926378-11926379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2355135 | chr7:11926424-11926425 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs528120323 | chr7:11926458-11926459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561098074 | chr7:11926488-11926489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2355136 | chr7:11926503-11926504 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs10229285 | chr7:11926516-11926517 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs550621419 | chr7:11926544-11926545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567888057 | chr7:11926549-11926550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs117288293 | chr7:11926564-11926565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553743935 | chr7:11926570-11926571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10272955 | chr7:11926573-11926574 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs372113898 | chr7:11926581-11926582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10243182 | chr7:11926585-11926586 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs11771848 | chr7:11927254-11927255 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs538227125 | chr7:11927273-11927274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554687040 | chr7:11927274-11927275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531735111 | chr7:11927300-11927301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183638550 | chr7:11927315-11927316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533987889 | chr7:11927361-11927362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552764901 | chr7:11927374-11927375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139183740 | chr7:11927393-11927394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546993037 | chr7:11927642-11927643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10277256 | chr7:11927672-11927673 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs141823344 | chr7:11927710-11927711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539021009 | chr7:11927711-11927712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11772691 | chr7:11927729-11927730 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs139948272 | chr7:11927756-11927757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143429252 | chr7:11927758-11927759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569371021 | chr7:11927759-11927760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146241212 | chr7:11927780-11927781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10277171 | chr7:11927782-11927783 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs117365002 | chr7:11927820-11927821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558627680 | chr7:11927828-11927829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs367576018 | chr7:11927832-11927833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6957533 | chr7:11927846-11927847 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs6957668 | chr7:11927862-11927863 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs553236538 | chr7:11927890-11927891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190356242 | chr7:11927893-11927894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574459086 | chr7:11927908-11927909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540359546 | chr7:11927935-11927936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10277646 | chr7:11927937-11927938 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs181263039 | chr7:11927950-11927951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546377721 | chr7:11927960-11927961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373671862 | chr7:11927966-11927967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs35280109 | chr7:11927986-11927987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562897157 | chr7:11928018-11928019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Medulloblastoma | 17653508 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 19242612 | CNVD |
Autism | 18414403 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Autism | 22495309 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:11926000-11926600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr7:11927200-11927400 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr7:11927600-11930800 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr7:11927600-11931800 | Weak transcription | Pancreas | Pancrea |
5 | chr7:11930800-11931600 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
6 | chr7:11931600-11932600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr7:11931800-11932000 | ZNF genes & repeats | Pancreas | Pancrea |
8 | chr7:11932600-11933000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr7:11934600-11935200 | Enhancers | Fetal Brain Female | brain |
10 | chr7:11935400-11936200 | Enhancers | Fetal Brain Male | brain |
11 | chr7:11935800-11936800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr7:11936200-11936800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr7:11936800-11937200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
14 | chr7:11937200-11937400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr7:11937400-11940200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |